Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population

Clinical trial NCT01337336 · COMPLETED

Trial details

NCT number: NCT01337336
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2010-10-01
Primary completion: 2010-11-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.